Covered recipient · General Payments record
LISA R CEBRUN MCCRAY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2025
$1,274.11
- Reported across 25 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.64 | 8 |
| Education | $95.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $129.26 | 2 |
| JAZZ PHARMACEUTICALS INC. | $107.17 | 1 |
| SANOFI-AVENTIS U.S. LLC | $101.89 | 1 |
| Syndax Pharmaceuticals, Inc. | $33.20 | 1 |
| Janssen Biotech, Inc. | $32.90 | 1 |
| Incyte Corporation | $29.41 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.14 | 1 |
| Gamida Cell Inc. | $23.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $34.26 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238729792 | CMS |
| Astellas Pharma US Inc | $95.00 | 08/02/2025 | Education | Undisputed | 06/30/2026 | 1238612600 | CMS |
| Gamida Cell Inc. | $23.67 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186327390 | CMS |
| Incyte Corporation | $29.41 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226072227 | CMS |
| Janssen Biotech, Inc. | $32.90 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175067974 | CMS |
| JAZZ PHARMACEUTICALS INC. | $107.17 | 09/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234883685 | CMS |
| SANOFI-AVENTIS U.S. LLC | $101.89 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233617554 | CMS |
| Syndax Pharmaceuticals, Inc. | $33.20 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238997772 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.14 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224077494 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.